DE2239091A1 - Pharmazeutische pulverzusammensetzung - Google Patents

Pharmazeutische pulverzusammensetzung

Info

Publication number
DE2239091A1
DE2239091A1 DE2239091A DE2239091A DE2239091A1 DE 2239091 A1 DE2239091 A1 DE 2239091A1 DE 2239091 A DE2239091 A DE 2239091A DE 2239091 A DE2239091 A DE 2239091A DE 2239091 A1 DE2239091 A1 DE 2239091A1
Authority
DE
Germany
Prior art keywords
microns
carrier
composition according
particle size
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
DE2239091A
Other languages
German (de)
English (en)
Inventor
Donald Ross Macarthur
David Ernest Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fisons Ltd
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36763080&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE2239091(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fisons Ltd filed Critical Fisons Ltd
Publication of DE2239091A1 publication Critical patent/DE2239091A1/de
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE2239091A 1971-08-10 1972-08-09 Pharmazeutische pulverzusammensetzung Ceased DE2239091A1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB3745671A GB1410588A (en) 1971-08-10 1971-08-10 Composition
DK392872A DK131891C (da) 1971-08-10 1972-08-09 Fremgangsmade til fremstilling af et pulverpreparat til inhalation
ZA730284A ZA73284B (en) 1971-08-10 1973-01-15 Pharmaceutical powder composition containing sodium cromoglycate
AU51191/73A AU5119173A (en) 1971-08-10 1973-01-17 Composition
ES410910A ES410910A1 (es) 1971-08-10 1973-01-24 Un procedimiento para la preparacion de una composicion farmaceutica en polvo para inhalacion.

Publications (1)

Publication Number Publication Date
DE2239091A1 true DE2239091A1 (de) 1973-02-22

Family

ID=36763080

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2239091A Ceased DE2239091A1 (de) 1971-08-10 1972-08-09 Pharmazeutische pulverzusammensetzung

Country Status (19)

Country Link
US (1) US4009280A (enExample)
JP (1) JPS5652001B2 (enExample)
AT (1) AT333974B (enExample)
AU (1) AU5119173A (enExample)
CA (1) CA992461A (enExample)
DE (1) DE2239091A1 (enExample)
DK (2) DK131891C (enExample)
ES (1) ES410910A1 (enExample)
FI (1) FI56487C (enExample)
FR (1) FR2150759B1 (enExample)
GB (1) GB1410588A (enExample)
IE (1) IE37102B1 (enExample)
IL (1) IL39990A (enExample)
LU (1) LU66875A1 (enExample)
NL (1) NL7210780A (enExample)
NO (1) NO140747C (enExample)
SE (1) SE411842B (enExample)
ZA (1) ZA73284B (enExample)
ZM (1) ZM11971A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4425255A1 (de) * 1994-07-16 1996-01-18 Asta Medica Ag Formulierung zur inhalativen Applikation

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5042826A (enExample) * 1973-08-20 1975-04-18
JPS5042819A (enExample) * 1973-08-20 1975-04-18
JPS5042827A (enExample) * 1973-08-20 1975-04-18
JPS6019043B2 (ja) * 1975-12-11 1985-05-14 ソニー株式会社 磁気再生装置
JPS5313111U (enExample) * 1976-07-16 1978-02-03
US4238502A (en) * 1978-08-03 1980-12-09 Fisons Limited Method of treating psychiatric conditions
BE891013A (fr) * 1980-11-05 1982-05-05 Fisons Ltd Compositions pharmaceutique
DE3636209A1 (de) * 1986-10-24 1988-04-28 Lentia Gmbh Verfahren zur herstellung eines bindemittelfreien tablettierfaehigen celiprololhydrochlorid-granulates
DE4140689B4 (de) * 1991-12-10 2007-11-22 Boehringer Ingelheim Kg Inhalationspulver und Verfahren zu ihrer Herstellung
GB9322014D0 (en) 1993-10-26 1993-12-15 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
GB9404945D0 (en) 1994-03-15 1994-04-27 Glaxo Group Ltd Pharmaceutical composition
GB9501841D0 (en) 1995-01-31 1995-03-22 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
US5747002A (en) * 1995-04-05 1998-05-05 Genentech, Inc. Preparation of sodium chloride aerosol formulations
US20020052310A1 (en) * 1997-09-15 2002-05-02 Massachusetts Institute Of Technology The Penn State Research Foundation Particles for inhalation having sustained release properties
US5985309A (en) * 1996-05-24 1999-11-16 Massachusetts Institute Of Technology Preparation of particles for inhalation
US5874064A (en) * 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
US6652837B1 (en) 1996-05-24 2003-11-25 Massachusetts Institute Of Technology Preparation of novel particles for inhalation
US7052678B2 (en) 1997-09-15 2006-05-30 Massachusetts Institute Of Technology Particles for inhalation having sustained release properties
DE69814428T2 (de) † 1997-09-29 2004-05-13 Nektar Therapeutics, San Carlos In verneblern verwendbare, stabilisierte zubereitungen
US20060165606A1 (en) * 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US6309623B1 (en) * 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US6956021B1 (en) 1998-08-25 2005-10-18 Advanced Inhalation Research, Inc. Stable spray-dried protein formulations
CA2382821A1 (en) * 1999-08-25 2001-03-01 Advanced Inhalation Research, Inc. Modulation of release from dry powder formulations
US6749835B1 (en) 1999-08-25 2004-06-15 Advanced Inhalation Research, Inc. Formulation for spray-drying large porous particles
US7678364B2 (en) 1999-08-25 2010-03-16 Alkermes, Inc. Particles for inhalation having sustained release properties
US20010036481A1 (en) * 1999-08-25 2001-11-01 Advanced Inhalation Research, Inc. Modulation of release from dry powder formulations
CA2382133C (en) 2000-05-10 2010-11-23 Alliance Pharmaceutical Corporation Phospholipid-based powders for drug delivery
US8404217B2 (en) * 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
WO2002009674A2 (en) * 2000-07-28 2002-02-07 Inhale Therapeutic Systems, Inc. Methods and compositions to upregulate, redirect or limit immune responses to bioactive compounds
US20020141946A1 (en) * 2000-12-29 2002-10-03 Advanced Inhalation Research, Inc. Particles for inhalation having rapid release properties
EP1345629A2 (en) 2000-12-29 2003-09-24 Advanced Inhalation Research, Inc. Particles for inhalation having sustained release properties
BR0207062A (pt) * 2001-02-06 2004-10-05 Innovata Biomed Ltd Composição farmacêutica bimodal, inalador para pó seco, método de aplicação de uma quantidade terapeuticamente eficaz de um ingrediente ativo substancialmente fino aos pulmões de um paciente, método de tratamento de um distúrbio respiratório, método de tratamento de doença pulmonar obstrutiva crÈnica (copd), uso de um agente antiinflamatório, uso de um broncodilatador, uso de uma mistura de um agente antiinflamatório e de um broncodilatador, e, processo para a fabricação de uma composição farmacêutica bimodal
CA2465675C (en) * 2001-11-20 2008-06-10 Advanced Inhalation Research, Inc. Improved particulate compositions for pulmonary delivery
AU2002346472A1 (en) * 2001-11-20 2003-06-10 Advanced Inhalation Research, Inc. Particulate compositions for improving solubility of poorly soluble agents
WO2003053411A1 (en) 2001-12-19 2003-07-03 Nektar Therapeutics Pulmonary delivery of aminoglycosides
US6889690B2 (en) * 2002-05-10 2005-05-10 Oriel Therapeutics, Inc. Dry powder inhalers, related blister devices, and associated methods of dispensing dry powder substances and fabricating blister packages
US7763280B2 (en) * 2002-11-28 2010-07-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing powder formulation for inhalation
US20070031342A1 (en) * 2005-06-22 2007-02-08 Nektar Therapeutics Sustained release microparticles for pulmonary delivery
KR101584390B1 (ko) * 2008-07-24 2016-01-11 레르 리키드 쏘시에떼 아노님 뿌르 레？드 에렉스뿔라따시옹 데 프로세데 조르즈 클로드 전이 금속 함유 필름의 침착을 위한 헤테로렙틱 시클로펜타디에닐 전이 금속 전구체

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3121096A (en) * 1961-12-27 1964-02-11 Roussel Uclaf New process of preparation of 3-methyl chromone
GB1144905A (en) * 1965-03-25 1969-03-12 Fisons Pharmaceuticals Ltd Substituted bis-(2-carboxy-chromonyl-oxy) derivatives and preparation and pharmaceutical compositions thereof
US3686412A (en) * 1965-03-25 1972-08-22 Colin Fitzmaurice Compositions containing bis-chromonyl compounds for inhibiting antigen-antibody reactions
GB1147976A (en) * 1965-12-21 1969-04-10 Fisons Pharmaceuticals Ltd Chromone derivatives
GB1190193A (en) * 1966-07-05 1970-04-29 Fisons Pharmaceuticals Ltd Bis-(2-Carboxy-Chromonyl-Oxy) Derivatives, their preparation, and Pharmaceutical Compositions thereof
GB1242211A (en) * 1967-08-08 1971-08-11 Fisons Pharmaceuticals Ltd Pharmaceutical composition
GB1223690A (en) * 1967-10-17 1971-03-03 Fisons Pharmaceuticals Ltd Substituted chromon-2-carboxylic acids
GB1292601A (en) * 1968-10-30 1972-10-11 Fisons Pharmaceuticals Ltd Bis-(2-carboxy-chromone) compounds, their preparation and pharmaceutical compositions containing them

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4425255A1 (de) * 1994-07-16 1996-01-18 Asta Medica Ag Formulierung zur inhalativen Applikation

Also Published As

Publication number Publication date
FI56487B (fi) 1979-10-31
DK146974C (da) 1984-08-13
AT333974B (de) 1976-12-27
ATA39073A (de) 1976-04-15
DK131891B (da) 1975-09-22
NO140747B (no) 1979-07-30
NO140747C (no) 1979-11-07
JPS5652001B2 (enExample) 1981-12-09
LU66875A1 (enExample) 1973-03-23
CA992461A (en) 1976-07-06
FR2150759B1 (enExample) 1975-10-31
DK131891C (da) 1976-02-23
US4009280A (en) 1977-02-22
IL39990A0 (en) 1972-09-28
DK535774A (enExample) 1975-06-02
ES410910A1 (es) 1976-07-16
JPS4826764A (enExample) 1973-04-09
GB1410588A (en) 1975-10-22
IL39990A (en) 1977-02-28
FI56487C (fi) 1980-02-11
IE37102B1 (en) 1977-05-11
ZM11971A1 (en) 1973-02-21
FR2150759A1 (enExample) 1973-04-13
DK146974B (da) 1984-03-05
NL7210780A (enExample) 1973-02-13
ZA73284B (en) 1973-11-28
SE411842B (sv) 1980-02-11
AU5119173A (en) 1974-07-18

Similar Documents

Publication Publication Date Title
DE2239091A1 (de) Pharmazeutische pulverzusammensetzung
DE4140689B4 (de) Inhalationspulver und Verfahren zu ihrer Herstellung
DE69631119T2 (de) Pulver zur verwendung in trockenpulverinhalatoren
DE1792207C3 (de) Pulverpräparat zur Inhalation
DE69631159T3 (de) Pulver und deren verwendung in trockenpulverinhalatoren
DE60003162T2 (de) Modifizierte trägerpartikel zur verwendung in trockenpulverinhalatoren
DE69907951T2 (de) Verbesserungen in bezug auf pulver
DE69828886T3 (de) Neuartige formulierung zur inhalation mit einer bulkdichte zwischen 0.28 und 0.38 g/ml, verfahren zur herstellung der formulierung sowie anwendung derselben
DE2229981C3 (de) Pharmazeutische Pulverpräparate
DE2851489A1 (de) Pharmazeutisches praeparat
DE3885084T2 (de) Mikrokristallin erscheinendes kalorienarmes Süssungsmittel.
EP1419373B1 (de) Vorrichtung zur bestimmung von aerosol-partikelgrössenverteilungen
DE3783039T2 (de) Membran lipid zusammensetzung und verfahren zur herstellung.
DE69022861T2 (de) Kryoschützende kristalline Sorbitolkügelchen.
DE60104399T2 (de) Pulverformulierung zur inhalation
DE60123031T2 (de) Pharmazeutische formulierungen für trockenpulverinhalatoren in form von hartpellets
CH652134A5 (de) Beclometasondipropionat-monohydrat von konstanter teilchengroesse und dieses enthaltende pharmazeutische zusammensetzung.
DE69839275T2 (de) Neue formulierung zur inhalation mit einer bulkdichte zwischen 0,28 und 0,38 g/ml enthaltend budensonide
DE69213836T2 (de) Megestrolazetat-Formulierung
DE69821119T2 (de) Neuartige formulierung zur inhalation mit einer bulkdichte zwischen 0.28 und 0.38 g/ml, mit formoterol
EP0358951B1 (de) Pulvrige, hydrophile Theophyllinformulierung und Verfahren zu ihrer Herstellung
DE2541459B2 (de) Verfahren zur herstellung staubfreier arzneilicher chinoxalin-1,4- dioxid-tierfuttermischungen
DE69817774T2 (de) Trägerstoff für trockenpulverinhalator, verfahren zu dessen herstellung und diesen enthaltende arzneimittel
DE69906147T2 (de) Zerkleinerungsverfahren zur herstellung von feingemahlenen medizinischen substanzen
DE3878978T2 (de) Galenische form eines trockenextraktes von pflanzen.

Legal Events

Date Code Title Description
OD Request for examination
8127 New person/name/address of the applicant

Owner name: FISONS PLC, IPSWICH, SUFFOLK, GB

8128 New person/name/address of the agent

Representative=s name: WUESTHOFF, F., DR.-ING. FRHR. VON PECHMANN, E., DI

8125 Change of the main classification

Ipc: A61K 31/35

8178 Suspension cancelled
8131 Rejection